Clinical Trials Insight: 700029371
Latest Information Update: 19 Dec 2007
Price :
$35 *
At a glance
- Drugs DDP 225 (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- Sponsors Dynogen Pharmaceuticals
- 19 Dec 2007 New trial record.